Sign in to fuzzto save your conversations, follow your research and come back anytime.
Fineotex Chemical
FCL
NSE
BSE
NSEBSESectorChemicals
48.41
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Fineotex Chemical scales revenue and profit sharply, though rising costs and expenses compress margins.
Revenue surged from ₹137.07 Cr to ₹376.63 Cr from Q1 FY26 to Q1 FY27, showing strong top-line momentum.
Net profit margin slipped from 18.26% to 12.80% from Q1 FY26 to Q1 FY27, reflecting profit dilution.
Net profit grew from ₹25.03 Cr to ₹48.21 Cr from Q1 FY26 to Q1 FY27, confirming robust bottom-line expansion.
Raw material costs surged from ₹91.11 Cr to ₹243.23 Cr from Q1 FY26 to Q1 FY27, signaling severe input cost inflation.
Gross margin held steady from 33.53% to 35.42% from Q1 FY26 to Q1 FY27, indicating stable pricing power.
Employee benefit expenses jumped from ₹6.20 Cr to ₹26.83 Cr from Q1 FY26 to Q1 FY27, indicating aggressive headcount expansion.
EBITDA climbed from ₹25.20 Cr to ₹59.14 Cr from Q1 FY26 to Q1 FY27, signaling strong operational cash generation.
EBITDA margin fell from 18.38% to 15.70% from Q1 FY26 to Q1 FY27, showing ongoing margin compression.